Metaraminol (Aramine®) in the management of a significant amlodipine overdose

Human and Experimental Toxicology

Volumn 24, Issue 7, 2005, Pages 377-381

  Wood, D M ^a,c   Wright, K D ^b   Jones, A L ^c   Dargan, P I ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Amlodipine; Aramine; Calcium channel blockers; Metaraminol; Overdose

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; CITALOPRAM; FLUOXETINE; FOLIC ACID; GLUCAGON; GLUCONATE CALCIUM; METARAMINOL; PARACETAMOL; PERINDOPRIL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; CASE REPORT; DRUG OVERDOSE; ELECTROCARDIOGRAM; GLASGOW COMA SCALE; HEART OUTPUT; HUMAN; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RESUSCITATION; SELF POISONING; TREATMENT FAILURE; URINE VOLUME; DRUG EFFECT; HEMODYNAMICS; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; SUICIDE ATTEMPT;

ADRENERGIC ALPHA-AGONISTS; ADULT; AMLODIPINE; CALCIUM CHANNEL BLOCKERS; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METARAMINOL; OVERDOSE; SUICIDE, ATTEMPTED;

EID: 23744475808     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327105ht538oa     Document Type: Article

References (54)

1. Lip GYH, Ferner RE. Poisoning with anti-hypertensive drugs: calcium antagonists. J Hum Hypertens 1995; 9: 155-61.
2. Cosbey SH, Carson DJL. A fatal case of amlodipine overdose. J Anal Toxicol 1997; 21: 221-22.
3. Koch AR, Vogelaers DP, Decruyenaere JM, Callens B, Verstraete A, Buylaert WA. Fatal intoxication with amlodipine. J Toxicol: Clin Toxicol 1995; 33: 253-56.
4. Johansen SS, Genner J. A fatal case of amlodipine poisoning. J Clin Forensic Med 2003; 10: 169-72.
5. Adams BD, Browne WT. Amlodipine overdose causes prolonged calcium channel blocker toxicity. Am J Emerg Med 1998; 16: 527-28.
6. Stanek EJ, Nelson CE, DeNofrio D. Amlodipine overdose. Ann Pharmacother 1997; 31: 853-56.
7. Yuan TH, Kerns WP 2nd, Tomaszewski CA, Ford MD, Kline JA. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol: Clin Toxicol 1999; 37: 463-74.
8. Feldman R, Glinska-Serwin M. Deep hypotension with transient oliguria and severe heart failure in course of acute intentional poisoning with amlodipine. Pol Arch Med Wewn 2001; 105: 495-99.
9. Rasmussen L, Husted SE, Johnsen SP. Severe intoxication after an intentional overdose of amlodipine. Acta Anaesthesiol Scand 2003; 47: 1038-40.
10. Salhanick SD, Shannon MW. Management of calcium channel antagonist overdose. Drug Saf 2003; 26: 65-79.
11. Zimmerman JL. Poisonings and overdoses in the intensive care unit: general and specific management issues. Crit Care Med 2003; 31: 2794-801.
12. Koury SI, Stone K, Thomas SH. Amrinone as an antidote in experimental verapamil overdose. Acad Emerg Med 1996; 3: 762-67.
13. Tuncok Y, Apaydin S, Gidener S, Guven H, Oto O, Ates M, Gure A. The effects of amrinone and glucagon on verapamil-induced myocardial depression in a rat isolated heart model. Gen Pharmacol 1997; 28: 773-76.
14. Alousi AA, Canter JM, Fort DJ. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog. Cardiovasc Res 1985; 19: 483-94.
15. Tuncok Y, Apanydin S, Kalkan S, Ales M, Guven H. The effects of amrinone and glucagon on verapamil-induced cardiovascular toxicity in anaesthetized rats. Int J Exper Pathol 1996; 77: 207-12.
16. Goenen M, Col J, Compere A, Bonte J. Treatment of severe verapamil poisoning with combined amrinone-isoproterenol therapy. Am J Cardiol 1986; 58: 1142-43.
17. Wolf LR, Spadafora MP, Otten EJ. Use of amrinone and glucagon in a case of calcium channel blocker overdose. Ann Emerg Med 1993; 22: 1225-28.
18. Belson MG, Gorman SE, Sullivan K, Geller RJ. Calcium channel blocker ingestions in children. Am J Emerg Med 2000; 18: 581-86.
19. Ramoska EA, Spiller HA, Winter M, Borys D. A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. Ann Emerg Med 1993; 22: 196-200.
20. Buckley CD, Aronson JK. Prolonged half-life of verapamil in a case of overdose: implications for therapy. Br J Clin Pharmacol 1995; 39: 680-83.
21. Howarth DM, Dawson AH, Smith AJ, Buckley N, Whyte IM. Calcium channel blocking drug overdose: an Australian series. Hum Exper Toxicol 1994; 13: 161-66.
22. Hoffman RS. What to do with case reports: is folly that succeeds folly nonetheless. J Toxicol: Clin Toxicol 2003; 41: 377-79.
23. Hack JB, Woody JH, Lewis DE, Brewer K, Meggs WJ. The effect of calcium chloride in treating hyperkalemia due to acute digoxin toxicity in a porcine model. J Toxicol: Clin Toxicol 2004; 42: 337-42.
24. Bania TC, Blaufeux B, Hughes S, Almond GL, Homel P. Calcium and digoxin vs. calcium alone for severe verapamil toxicity. Acad Emerg Med 2000; 7: 1089-96.
25. Stone CK, May WA, Carroll R. Treatment of verapamil overdose with glucagon in dogs. Ann Emerg Med 1995; 25: 369-74.
26. Stone CK, Thomas SH, Koury SI, Low RB. Glucagon and phenylephrine combination vs glucagon alone in experimental verapamil overdose. Acad Emerg Med 1996; 3: 120-25.
27. Levey GS, Fletcher MA, Klein I, Ruiz E, Schenk A. Characterization of 125I-glucagon binding in a solubilized preparation of cat myocardial adenylate cyclase: further evidence for a dissociable receptor site. J Biol Chem 1974; 249: 2665-73.
28. 2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase. Nature 1990; 345: 158-61.
29. 2+ mobilization in cardiac cells. Circ Res 1996; 78: 102-109.
30. Doyon S, Roberts JR. The use of glucagon in a case of calcium channel blocker overdose. Ann Emerg Med 1993; 22: 1229-33.
31. Walter FG, Frye G, Mullen JT, Ekins BR, Khasigian PA. Amelioration of nifedipine poisoning associated with glucagon therapy. Ann Emerg Med 1993; 22: 1225-28.
32. Calcium channel blockers. In Jones AL, Dargan PI eds. Churchill's pocketbook of toxicology, first edition, Volume 2. London: Churchill Livingstone, 2001: 40-41.
33. Enyeart JJ, Price WA, Hoffman DA, Woods L. Profound hyperglycaemia and metabolic acidosis after verapamil overdose. J Am Coll Cardiol 1983; 2: 1228-31.
34. Kline JA, Raymond RM, Schroeder JD, Watts JA. The diabetogenic effects of acute verapamil poisoning. Toxicol Appl Pharmacol 1997; 145: 357-62.
35. Kline JA, Leonova E, Raymond RM. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med 1995; 23: 1251-63.
36. Farah AE, Alousi AA. The actions of insulin on cardiac contractility. Life Sci 1981; 29: 975-1000.
37. Boyer EW, Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. New Engl J Med 2001; 344: 1721-22.
38. Marques M, Gomes E, Oliveira J. Treatment of calcium channel blocker intoxication with insulin infusion: case report and literature review. Resuscitation 2003; 57: 211-13.
39. Lehtonen LA, Antila A, Pentiakainen PJ. Pharmacokinetics and pharmacodynamics of intravenous inotropic agents. Clin Pharmacokinet 2004; 43: 187-203.
40. Kee VR. Hemodynamic pharmacology of intravenous vasopressors. Crit Care Nurse 2003; 23: 79-82.
41. Kulka PJ, Tryba M. Inotropic support of the critically ill patient - a review of the agents. Drugs 1993; 45: 654-67.
42. Fischer TA, Erbel R, Tresse N. Current status of phosphodiesterase inhibitors in the treatment of congestive cardiac failure. Drugs 1992; 44: 928-45.
43. Evans DB. Modulation of c-AMP mechanism for positive inotropic agents. J Cardiovasc Pharmacol 1986; 8: S22-S29.
44. Lancon JP, Caillard B, Obadia JF, Volot F, Baeufils-Leblanc C. Haemodynamic evaluation of milrinone, a new phosphodiesterase inhibitor, in the treatment of low cardiac output state after cardiac surgery. J Cardiothorac Vasc Anesth 1992; 6(Suppl 1): 68.
45. Chiu CL, Tew GP, Wang CY. The effect of prophylactic metaraminol on systemic hypotension caused by induction of anaesthesia with propofol in patients over 55 years old. Anaesthesia 2001; 56: 893-97.
46. Kajimoto Y, Nishimura N. Metaraminol and dobutamine for the treatment of hypotension associated with epidural block. Resuscitation 1984; 12: 47-51.
47. Critchley LAH, Conway F. Hypotension during subarachnoid anaesthesia: haemodynamic effects of colloid and metaraminol. Br J Anaesth 1996; 76: 734-36.
48. Critchley LAH, Yu SC. A comparative study of three different methods of administering metaraminol during spinal anaesthesia in the elderly. Anaesth Intensive Care 2001; 29: 141-48.
49. Critchley LAH, Karmakar MK, Cheng JHH, Critchley JAJH. A study to determine the optimum dose of metaraminol required to increase blood pressure by 25% during subarachnoid anaesthesia. Anaesth Intensive Care 1999; 27: 170-74.
50. Sagie A, Sclarvosky S, Klainman E, Strasberg B, Rechavia E, Mager A, Kusniec J, Agmon J. Effect of metaraminol during acute inferior wall myocardial infarction accompanied by hypotension: preliminary study. J Am Coll Cardiol 1987; 10: 1139-44.
51. Figueras J, Lidon RM, Cortadellas J. Metaraminol-induced reversal of acute myocardial ischaemia associated with hypotension and refractory to intravenous nitroglycerin. Eur Heart J 1991; 12: 720-25.
52. Dagher E, Dumont L, Chartrand C. Positive haemodynamic interaction between amrinone and Diltiazem in anaesthetized dogs. Can J Physiol Pharmacol 1989; 67: 1092-97.
53. Varughese A, Taylor AA, Nelson EB. Consequences of angiotensin-converting enzyme inhibitor overdose. Am J Hypertens 1989; 2: 355-57.
54. Lip GY, Ferner RE. Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors. J Hum Hypertens 1995; 9: 711-15.